De Letter Els A, Belpaire Frans M, Clauwaert Karine M, Lambert Willy E, Van Bocxlaer Jan F, Piette Michel H A
Ghent University, Department of Forensic Medicine, J. Kluyskensstraat 29, 9000 Ghent, Belgium.
Int J Legal Med. 2002 Aug;116(4):225-32. doi: 10.1007/s00414-002-0293-z. Epub 2002 Jun 4.
Drug concentrations in autopsy samples can also be influenced by post-mortem gastric diffusion when the stomach contains a substantial amount of the drug or by diffusion from the trachea when agonal aspiration or post-mortem regurgitation of vomit occurs. This was studied in a rabbit animal model in which MDMA solutions were infused post mortem either in the trachea or in the stomach. At 24, 48 or 72 h post mortem, samples including cardiac blood, vitreous humour, urine, bile, gastric content and several tissues were taken for toxicological analysis. After post-mortem tracheal infusion, MDMA can easily diffuse not only into the lungs but also in great quantities into the cardiac blood and, to a lesser extent, into the cardiac muscle. MDMA was also found in the closely adjacent diaphragm and in the upper abdominal organs, including the liver and the stomach. Following post-mortem infusion into the stomach, considerable MDMA levels were found in cardiac blood and muscle, both lungs, diaphragm and liver tissue when the solution was concentrated nearby the lower oesophageal sphincter. However, when the MDMA solution was present deeper in the stomach, MDMA levels were high in the spleen and the liver and relatively low in cardiac blood and muscle. In both experiments, MDA levels in most tissues were low or below the limit of quantitation, but were substantial in cardiac blood and muscle, lungs and diaphragm, indicating that MDMA can be metabolised to MDA after death. These results in the rabbit model indicate that the diffusion of MDMA out of the stomach content, or due to aspirated vomit and gastro-oesophageal reflux can lead to considerable post-mortem redistribution and thus should be taken into account in current forensic practice in order to draw the right conclusions when a peripheral blood sample is not available.
当胃中含有大量药物时,尸检样本中的药物浓度会受到死后胃扩散的影响;当濒死期出现吸入或死后呕吐反流时,药物浓度会受到来自气管扩散的影响。这在一个兔动物模型中进行了研究,在该模型中,死后将摇头丸溶液注入气管或胃中。在死后24、48或72小时,采集包括心脏血液、玻璃体液、尿液、胆汁、胃内容物和几种组织的样本进行毒理学分析。死后经气管注入后,摇头丸不仅能轻易扩散到肺部,还能大量扩散到心脏血液中,在较小程度上扩散到心肌中。在紧邻的膈肌以及包括肝脏和胃在内的上腹部器官中也发现了摇头丸。死后将溶液注入胃中后,当溶液集中在食管下括约肌附近时,在心脏血液、肌肉、双侧肺、膈肌和肝脏组织中发现了相当高的摇头丸水平。然而,当摇头丸溶液存在于胃的更深部位时,脾脏和肝脏中的摇头丸水平较高,而心脏血液和肌肉中的水平相对较低。在这两个实验中,大多数组织中的MDA水平较低或低于定量限,但在心脏血液、肌肉、肺和膈肌中含量较高,这表明摇头丸在死后可代谢为MDA。兔模型中的这些结果表明,摇头丸从胃内容物中扩散出来,或由于吸入呕吐物和胃食管反流,可导致死后相当程度的重新分布,因此在当前法医实践中,当无法获得外周血样本时,为了得出正确结论,应考虑到这一点。